Citadel Advisors
SKIN icon

Citadel Advisors’s SkinHealth Systems SKIN Stock Holding History

Citadel Advisors’s Portfolio SKIN Stock Details SKIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$118K Buy
170,300
+127,320
+296% +$97.3K ﹤0.01% 12554
2026
Q1 		$38.3K Sell
42,980
-69,251
-62% -$85K ﹤0.01% 12506
2025
Q4 		$156K Sell
112,231
-342,395
-75% -$495K ﹤0.01% 11271
2025
Q3 		$905K Buy
454,626
+365,134
+408% +$741K ﹤0.01% 7748
2025
Q2 		$171K Buy
+89,492
New +$126K ﹤0.01% 10835
2025
Q1 		– Sell
-101,611
Closed -$155K – 15472
2024
Q4 		$162K Buy
+101,611
New +$160K ﹤0.01% 10775
2024
Q3 		– Sell
-31,966
Closed -$52.4K – 15154
2024
Q2 		$61.4K Sell
31,966
-1,214,734
-97% -$3.42M ﹤0.01% 11539
2024
Q1 		$5.54M Buy
1,246,700
+469,609
+60% +$1.53M ﹤0.01% 3794
2023
Q4 		$2.42M Sell
777,091
-211,028
-21% -$792K ﹤0.01% 5032
2023
Q3 		$5.95M Buy
988,119
+641,808
+185% +$4.51M ﹤0.01% 3382
2023
Q2 		$2.9M Sell
346,311
-743,165
-68% -$7.72M ﹤0.01% 4536
2023
Q1 		$13.8M Sell
1,089,476
-704,636
-39% -$8.15M ﹤0.01% 2391
2022
Q4 		$16.3M Buy
1,794,112
+612,328
+52% +$6.61M ﹤0.01% 2183
2022
Q3 		$13.9M Buy
1,181,784
+968,890
+455% +$12.2M ﹤0.01% 2313
2022
Q2 		$2.74M Sell
212,894
-1,432,459
-87% -$19.2M ﹤0.01% 4930
2022
Q1 		$27.8M Buy
1,645,353
+345,317
+27% +$5.7M 0.01% 1625
2021
Q4 		$31.4M Sell
1,300,036
-271,018
-17% -$6.98M 0.01% 1555
2021
Q3 		$40.8M Sell
1,571,054
-1,586,464
-50% -$34.9M 0.01% 1288
2021
Q2 		$53M Buy
3,157,518
+3,127,260
+10,335% +$42.8M 0.01% 1082
2021
Q1 		$327K Buy
+30,258
New +$333K ﹤0.01% 10643

Other funds holding SKIN

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citadel Advisors's SKIN Position: Q2 2026 in Review

Citadel Advisors increased its SkinHealth Systems (SKIN) stake by 296% in Q2 2026, buying an estimated $97.3K and bringing the position to 170,300 shares worth $118K. The position accounts for ﹤0.01% of the portfolio, ranked #12554.

Citadel Advisors first reported a position in SKIN in Q1 2021 and has held it in 20 quarters since. The position peaked at $53M in Q2 2021. 96 funds tracked by Wall St. Rank hold SKIN as of Q2 2026.

  • Citadel Advisors held 170,300 shares of SkinHealth Systems worth $118K as of Q2 2026.
  • Citadel Advisors bought 127,320 SkinHealth Systems shares in Q2 2026, an estimated $97.3K.
  • SkinHealth Systems made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #12554 holding.
  • Citadel Advisors first reported a position in SkinHealth Systems in Q1 2021 and has held it in 20 quarters since.
  • Citadel Advisors's SkinHealth Systems position peaked at $53M in Q2 2021.
  • 96 funds tracked by Wall St. Rank held SkinHealth Systems as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.